EarningsQ4 2025 Earnings Report

BridgeBio Pharma (2CL) Q4 2025 Earnings Report

3 Followers

DE:2CL Q4 2025 EPS Results

Actual EPS-€0.89

Consensus EPS-€0.64

Beat/MissMissed by -€0.26

One Year Ago EPS-€1.25

Actual Revenue€137.50M

Expected Revenue€130.95M

Beat/MissBeat by +€6.55M

YoY Revenue Growth+2521.18%

QuarterQ4 2025

Date02/24/2026

TimeAfter Close

Conference CallTuesday, February 24, 2026

DE:2CL Upcoming Earnings

BridgeBio Pharma's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

DE:2CL Q4 2025 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	-0.53 / -	-0.847	―
Aug 10, 2026	2026 (Q2)	-0.51 / -0.70	-0.847	17.89% (+0.15)
May 07, 2026	2026 (Q1)	-0.61 / -0.75	-0.785	4.55% (+0.04)
Feb 24, 2026	2025 (Q4)	-0.64 / -0.89	-1.249	28.57% (+0.36)
Oct 29, 2025	2025 (Q3)	-0.80 / -0.85	-0.767	-10.47% (-0.08)
Aug 05, 2025	2025 (Q2)	-0.71 / -0.85	-0.348	-143.59% (-0.50)
Apr 29, 2025	2025 (Q1)	-0.82 / -0.78	-0.178	-340.00% (-0.61)
Feb 20, 2025	2024 (Q4)	-1.00 / -1.25	-0.856	-45.83% (-0.39)
Nov 12, 2024	2024 (Q3)	-0.89 / -0.77	-0.963	20.37% (+0.20)
Aug 01, 2024	2024 (Q2)	-0.89 / -0.35	-0.874	60.20% (+0.53)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed